Identification of novel therapeutic approaches for paediatric high-grade gliomas

We are planning to use a combination of mouse and patient-derived models to identify novel therapeutic approaches for pHGGs.

Previous PostLeveraging existing pediatric low-grade tumor specimens, clinical and imaging outcome data and artificial intelligence innovations to develop integrated biomarkers of response for children with low-grade glioma
Next PostDIPG International Prevalence of Germline Mutations (DIPG-M)